ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 609

$2.71M Total Retail Price of All Prescriptions

Rank: 1 out of 609

811 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 811 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

6% of this provider’s 811 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 26,694 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 815 753 1 2
OMEPRAZOLE 767 684 2 3
NAMENDA 735 699 3 36
LEVOTHYROXINE SODIUM 688 629 4 7
DONEPEZIL HCL 564 561 5 22
SIMVASTATIN 564 480 5 1
ZOLPIDEM TARTRATE 528 483 7 18
METOPROLOL SUCCINATE 526 481 8 5
METFORMIN HCL 526 446 8 10
ALENDRONATE SODIUM 468 412 10 54
DIOVAN HCT 459 433 11 31
LISINOPRIL 458 395 12 12
FENOFIBRATE 431 404 13 143
FUROSEMIDE 359 337 14 4
NEXIUM 337 301 15 13
CRESTOR 332 300 16 16
CELEBREX 320 292 17 60
DOXAZOSIN MESYLATE 318 310 18 129
HYDROCHLOROTHIAZIDE 306 288 19 20
CARVEDILOL 303 282 20 14
POTASSIUM CHLORIDE 296 281 21 40
LOVAZA 294 255 22 73
MIRTAZAPINE 280 279 23 58
CLOPIDOGREL 279 276 24 17
EVISTA 268 261 25 207
MELOXICAM 252 201 26 55
LOSARTAN POTASSIUM 244 222 27 24
AMLODIPINE BESYLATE-BENAZEPRIL 243 231 28 88
GLIMEPIRIDE 239 209 29 53
LOSARTAN-HYDROCHLOROTHIAZIDE 231 215 30 69
MECLIZINE HCL 228 216 31 144
FLUOXETINE HCL 226 195 32 148
ATORVASTATIN CALCIUM 221 201 33 6
EXELON 221 221 33 142
TAMSULOSIN HCL 215 212 35 11
VOLTAREN 199 190 36 159
LACTULOSE 197 180 37 109
PLAVIX 196 193 38 25
DEXILANT 195 181 39 87
NAPROXEN 194 163 40 98
PANTOPRAZOLE SODIUM 192 183 41 29
LIDODERM 170 147 42 81
DIOVAN 165 160 43 15
IBUPROFEN 164 140 44 103
MEGACE ES 164 159 R 10 44 312
BYSTOLIC 160 148 46 71
IBANDRONATE SODIUM 159 141 47 195
METOPROLOL TARTRATE 158 151 48 9
JANUMET 153 144 49 119
ACTONEL 151 146 50 219
ATENOLOL-CHLORTHALIDONE 147 128 51 356
ACARBOSE 147 114 51 226
ISOSORBIDE MONONITRATE ER 143 142 53 62
EXFORGE HCT 141 127 54 265
OXYBUTYNIN CHLORIDE ER 140 137 55 114
GLYBURIDE-METFORMIN HCL 139 131 R 56 149
TRICOR 138 126 57 130
TRAMADOL HCL 137 113 58 39
CYMBALTA 136 129 59 76
DIVALPROEX SODIUM 135 120 60 101
LANTUS SOLOSTAR 135 117 60 63
FAMOTIDINE 132 132 62 50
PAROXETINE HCL 131 131 63 123
TORSEMIDE 130 130 64 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 126 65 77
PREDNISONE 129 112 65 26
ADVAIR DISKUS 128 104 67 28
SINGULAIR 126 108 68 78
AZITHROMYCIN 125 110 69 67
WARFARIN SODIUM 124 114 70 8
SPIRONOLACTONE 124 120 70 105
ALLOPURINOL 124 124 70 75
ESCITALOPRAM OXALATE 122 114 73 91
VERAPAMIL ER 119 119 74 168
AVODART 116 114 75 38
CLOTRIMAZOLE-BETAMETHASONE 115 111 76 135
CYCLOBENZAPRINE HCL 115 103 R 76 95
LANTUS 113 102 78 82
DILTIAZEM 24HR CD 106 106 79 154
BISOPROLOL FUMARATE 106 94 79 228
NABUMETONE 105 90 81 164
FLUTICASONE PROPIONATE 104 92 82 52
SPIRIVA 103 99 83 43
FINASTERIDE 102 102 84 37
NATEGLINIDE 95 80 85 172
LEVETIRACETAM 95 90 85 70
CITALOPRAM HBR 93 90 87 112
PROAIR HFA 93 90 87 57
TRIBENZOR 90 90 89 396
BENICAR HCT 89 74 90 232
AMMONIUM LACTATE 89 81 90 192
TRAMADOL HCL-ACETAMINOPHEN 87 69 92 102
LANSOPRAZOLE 87 79 92 178
METFORMIN HCL ER 84 60 94 115
VESICARE 84 80 94 80
DIGOXIN 82 82 96 33
NOVOLOG 82 71 96 156
KETOCONAZOLE 81 76 98 118
ACTOS 80 74 99 145
MONTELUKAST SODIUM 79 71 100 152
ZETIA 75 46 101 89
PRAVASTATIN SODIUM 72 63 102 35
BONIVA 71 68 103 263
SPIRONOLACTONE-HCTZ 70 59 104 422
ATELVIA 69 65 105 188
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 62 105 94
ENABLEX 67 67 107 110
VENLAFAXINE HCL ER 67 63 107 221
EXFORGE 67 56 107 214
INDAPAMIDE 67 62 107 429
VALACYCLOVIR 65 58 111 323
OLANZAPINE 65 65 111 174
ATENOLOL 65 61 111 27
JANUVIA 65 46 111 34
PRANDIN 64 60 115 181
GLIPIZIDE 64 36 115 169
NASONEX 63 60 117 149
HYDROCODONE BIT-IBUPROFEN 63 59 S3 117 437
PROMETHAZINE VC 62 56 R 119 440
BENAZEPRIL HCL 62 54 119 322
FENTANYL 62 62 S2 119 66
BISOPROLOL-HYDROCHLOROTHIAZIDE 58 50 122 303
RAMIPRIL 58 58 122 46
CLONIDINE HCL 58 44 122 83
LEXAPRO 57 52 125 384
VALSARTAN-HYDROCHLOROTHIAZIDE 57 53 125 309
RANITIDINE HCL 56 55 127 141
BETAMETHASONE DIPROPIONATE 56 47 127 261
NITROGLYCERIN PATCH 56 56 127 120
SUCRALFATE 56 41 127 276
WELCHOL 55 50 131 225
MEGESTROL ACETATE 55 55 R 131 243
GLYBURIDE 54 29 R 133 132
ANASTROZOLE 54 54 133 74
PRADAXA 52 52 135 106
LABETALOL HCL 52 51 135 316
NIFEDIPINE ER 50 42 137 230
RISPERIDONE 50 38 137 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.